Your session is about to expire
← Back to Search
Doxycycline for Chlamydia
Study Summary
This trial will test different courses of doxycycline to treat chlamydia infections in men and women.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I plan to take antibiotics that work against chlamydia during the study.I experience lower abdominal or pelvic pain and may have pelvic inflammatory disease.My doctor thinks I need a long-term treatment with doxycycline.I have untreated chlamydia, confirmed by a test within the last 14 days.I haven't taken medications like retinoids or warfarin in the last 7 days.I am at least 16 years old, or 18 where required.I am willing to avoid unprotected sex during the trial.I haven't taken specific antibiotics for chlamydia in the last 21 days.I am participating in another study using treatments for C. trachomatis.
- Group 1: Arm 1
- Group 2: Arm 3
- Group 3: Arm 2
- Group 4: Arm 4
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the study currently recruiting participants?
"Per the clinicaltrials.gov website, this trial has closed its recruitment period and is no longer searching for potential candidates. Initially posted on June 1st 2023 and updated as recently as April 21st 2023, there are 761 other studies actively recruiting patients at present."
Has the three-day regimen of doxycycline been sanctioned by the FDA?
"Leveraging the Phase 4 trial data, our team at Power determined that 3-Day Regimen of Doxycycline had an overall safety rating of 3."
Are there myriad locations in Canada undertaking this trial?
"According to the protocol, Grady Infectious Diseases Clinic (Ponce Clinic) in Rochester, University of Rochester in Seattle, and University of Washington Harborview Medical Center in Mombasa are 3 sites participating. Additionally, there exist 6 additional clinical trial locations."
What are the goals of this experimental endeavor?
"The primary outcome that will be assessed after 29 days is the Number of Participants with Microbiological Cure of Urogenital Infection in Persons Assigned Female at Birth (AFAB). Subsequent measures include: Quantity of Patients with a Negative NAAT Result for Urethral Infection in Males, Amount of Subjects Achieving Total CT Eradication from AFAB Anatomic Sites, and Sum of People Reaching Total CT Removal from AMAB Locations."
Share this study with friends
Copy Link
Messenger